+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Buerger's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Buerger's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Heart Failure - Pipeline Insight, 2024 - Product Thumbnail Image

Heart Failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 300 Pages
  • Global
From
Polypoidal choroidal vasculopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Polypoidal choroidal vasculopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Pericarditis - Pipeline Insight, 2024 - Product Thumbnail Image

Pericarditis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Diabetic Cardiomyopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Cardiomyopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Vascular Calcification - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Calcification - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Hypovolemic shock - Pipeline Insight, 2024 - Product Thumbnail Image

Hypovolemic shock - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Giant-Cell Arteritis - Pipeline Insight, 2024 - Product Thumbnail Image

Giant-Cell Arteritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
WAYLIVRA Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

WAYLIVRA Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
CSL112 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

CSL112 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
FDY-5301 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

FDY-5301 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
Olpasiran Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Olpasiran Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
Ventricular Tachycardia (V-tach or VT) - Pipeline Insight, 2024 - Product Thumbnail Image

Ventricular Tachycardia (V-tach or VT) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Critical Limb Ischemia - Pipeline Insight, 2024 - Product Thumbnail Image

Critical Limb Ischemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Coronary Artery Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Coronary Artery Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Congenital Heart Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Congenital Heart Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more